Rapid Response of Advanced Squamous Non-Small Cell Lung Cancer with Thrombocytopenia after First-Line Treatment with Pembrolizumab Plus Autologous Cytokine-Induced Killer Cells

We present the first clinical evidence of advanced squamous non-small cell lung cancer with severe thrombocytopenia showing dramatic improvement after first-line treatment with pembrolizumab plus autologous cytokine-induced killer cells.

Detalles Bibliográficos
Autores principales: Hui, Zhenzhen, Zhang, Xinwei, Ren, Baozhu, Li, Runmei, Ren, Xiubao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2015
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4681774/
https://www.ncbi.nlm.nih.gov/pubmed/26734004
http://dx.doi.org/10.3389/fimmu.2015.00633
_version_ 1782405768071348224
author Hui, Zhenzhen
Zhang, Xinwei
Ren, Baozhu
Li, Runmei
Ren, Xiubao
author_facet Hui, Zhenzhen
Zhang, Xinwei
Ren, Baozhu
Li, Runmei
Ren, Xiubao
author_sort Hui, Zhenzhen
collection PubMed
description We present the first clinical evidence of advanced squamous non-small cell lung cancer with severe thrombocytopenia showing dramatic improvement after first-line treatment with pembrolizumab plus autologous cytokine-induced killer cells.
format Online
Article
Text
id pubmed-4681774
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-46817742016-01-05 Rapid Response of Advanced Squamous Non-Small Cell Lung Cancer with Thrombocytopenia after First-Line Treatment with Pembrolizumab Plus Autologous Cytokine-Induced Killer Cells Hui, Zhenzhen Zhang, Xinwei Ren, Baozhu Li, Runmei Ren, Xiubao Front Immunol Immunology We present the first clinical evidence of advanced squamous non-small cell lung cancer with severe thrombocytopenia showing dramatic improvement after first-line treatment with pembrolizumab plus autologous cytokine-induced killer cells. Frontiers Media S.A. 2015-12-17 /pmc/articles/PMC4681774/ /pubmed/26734004 http://dx.doi.org/10.3389/fimmu.2015.00633 Text en Copyright © 2015 Hui, Zhang, Ren, Li and Ren. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Immunology
Hui, Zhenzhen
Zhang, Xinwei
Ren, Baozhu
Li, Runmei
Ren, Xiubao
Rapid Response of Advanced Squamous Non-Small Cell Lung Cancer with Thrombocytopenia after First-Line Treatment with Pembrolizumab Plus Autologous Cytokine-Induced Killer Cells
title Rapid Response of Advanced Squamous Non-Small Cell Lung Cancer with Thrombocytopenia after First-Line Treatment with Pembrolizumab Plus Autologous Cytokine-Induced Killer Cells
title_full Rapid Response of Advanced Squamous Non-Small Cell Lung Cancer with Thrombocytopenia after First-Line Treatment with Pembrolizumab Plus Autologous Cytokine-Induced Killer Cells
title_fullStr Rapid Response of Advanced Squamous Non-Small Cell Lung Cancer with Thrombocytopenia after First-Line Treatment with Pembrolizumab Plus Autologous Cytokine-Induced Killer Cells
title_full_unstemmed Rapid Response of Advanced Squamous Non-Small Cell Lung Cancer with Thrombocytopenia after First-Line Treatment with Pembrolizumab Plus Autologous Cytokine-Induced Killer Cells
title_short Rapid Response of Advanced Squamous Non-Small Cell Lung Cancer with Thrombocytopenia after First-Line Treatment with Pembrolizumab Plus Autologous Cytokine-Induced Killer Cells
title_sort rapid response of advanced squamous non-small cell lung cancer with thrombocytopenia after first-line treatment with pembrolizumab plus autologous cytokine-induced killer cells
topic Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4681774/
https://www.ncbi.nlm.nih.gov/pubmed/26734004
http://dx.doi.org/10.3389/fimmu.2015.00633
work_keys_str_mv AT huizhenzhen rapidresponseofadvancedsquamousnonsmallcelllungcancerwiththrombocytopeniaafterfirstlinetreatmentwithpembrolizumabplusautologouscytokineinducedkillercells
AT zhangxinwei rapidresponseofadvancedsquamousnonsmallcelllungcancerwiththrombocytopeniaafterfirstlinetreatmentwithpembrolizumabplusautologouscytokineinducedkillercells
AT renbaozhu rapidresponseofadvancedsquamousnonsmallcelllungcancerwiththrombocytopeniaafterfirstlinetreatmentwithpembrolizumabplusautologouscytokineinducedkillercells
AT lirunmei rapidresponseofadvancedsquamousnonsmallcelllungcancerwiththrombocytopeniaafterfirstlinetreatmentwithpembrolizumabplusautologouscytokineinducedkillercells
AT renxiubao rapidresponseofadvancedsquamousnonsmallcelllungcancerwiththrombocytopeniaafterfirstlinetreatmentwithpembrolizumabplusautologouscytokineinducedkillercells

Ejemplares similares